Seegene Inc.

Seegene Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

[INTRODUCING OUR COMPANY] The people of Seegene are on a purposeful mission to improve the world we live in. We aim to improve the quality of life for everyone globally by bringing molecular diagnostics to the masses. Molecular diagnostics is the most effective method to accurately diagnose ailments and is also the best way to diagnose them early which is when you can make the most difference in the recovery treatment. With industry-leading IP in molecular diagnostics reagent assays, we are dedicated to leveraging our unique technologies to increase our product portfolio, expand our market coverage, and lowering the total cost to serve our customers so that molecular diagnostics become a part of the fabric of everyone’s life and thus, improving the quality of life for everyone in the world. [OUR HISTORY AND OUR FUTURE] Since our founding in 2000, we have been steadfastly focused on molecular diagnostics. Currently, our product portfolio consists of over 250 molecular diagnostics reagent kits as well as a wide range of instruments and consumables that are sold globally. Testament to our expertise, when the pandemic started, Seegene was one of the first companies in the world to provide testing kits that were crucial in the fight against COVID. Today, we are a company with revenue of over $1 billion dollars and 65% gross margins. With 8 overseas entities, we generate a majority of our revenue outside of Korea. In keeping with our spirit of innovation and making a difference in the world, there are many exciting innovations being worked on at Seegene which will make it easier for the world to access the benefits of molecular diagnostics. We are transforming our business from a discrete reagent assay and instruments business to a platform business that will create new markets for molecular diagnostics and improve the quality of life for everyone. We hope that you will join us in our mission to make a meaningful difference in the world.
Looking for a particular Seegene Inc. employee's phone or email?

Seegene Inc. Questions

News

Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants - PR Newswire

Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants PR Newswire

Seegene unveils the world's first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025 - The Korea Herald

Seegene unveils the world's first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025 The Korea Herald

Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation - PR Newswire UK

Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation PR Newswire UK

Impact of Whole Slide Image Blurriness on the Robustness of Artificial Intelligence in Real World Setting: Retrospective Observational Study - medRxiv

Impact of Whole Slide Image Blurriness on the Robustness of Artificial Intelligence in Real World Setting: Retrospective Observational Study medRxiv

Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics - aap.com.au

Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics aap.com.au

Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation - The Korea Herald

Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation The Korea Herald

Seegene leads the way toward ‘a world free from all diseases' with Azure AI - Microsoft

Seegene leads the way toward ‘a world free from all diseases' with Azure AI Microsoft

Seegene: Unlocking the potential of molecular diagnostics - Nature

Seegene: Unlocking the potential of molecular diagnostics Nature

A Graphene-Coated Silicon Wafer Plate Improves the Sensitivity and Reproducibility of MALDI-TOF MS Analysis of Proteins - ACS Publications

A Graphene-Coated Silicon Wafer Plate Improves the Sensitivity and Reproducibility of MALDI-TOF MS Analysis of Proteins ACS Publications

Seegene Previews Modular End-to-End PCR Automation System at ADLM - 360Dx

Seegene Previews Modular End-to-End PCR Automation System at ADLM 360Dx

Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.Company expands presence and support in US market - BioSpace

Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.Company expands presence and support in US market BioSpace

Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration - PR Newswire Canada

Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration PR Newswire Canada

Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics - 美通社

Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics 美通社

Seegene Unveils HPV Genotyping Solution at EUROGIN 2025 - BioSpace

Seegene Unveils HPV Genotyping Solution at EUROGIN 2025 BioSpace

Korea's Seegene unveils next-gen fully automated PCR solution Cureca - BioSpectrum Asia

Korea's Seegene unveils next-gen fully automated PCR solution Cureca BioSpectrum Asia

Long-term trends in cycle threshold values: a comprehensive analysis of COVID-19 dynamics, viral load, and reproduction number in South Korea - Frontiers

Long-term trends in cycle threshold values: a comprehensive analysis of COVID-19 dynamics, viral load, and reproduction number in South Korea Frontiers

Seegene selects Microsoft as technology partner - World Business Outlook

Seegene selects Microsoft as technology partner World Business Outlook

Seegene Establishes Joint Venture in Mexico - PR Newswire

Seegene Establishes Joint Venture in Mexico PR Newswire

Seegene's losses continue amid market challenges - koreabiomed.com

Seegene's losses continue amid market challenges koreabiomed.com

Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1 - Macau Business

Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1 Macau Business

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative - 팜뉴스

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative 팜뉴스

SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results - ScienceDirect.com

SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results ScienceDirect.com

Seegene Reports 12.8% Revenue Growth Amid Strong Demand for Diagnostic Reagents - Businesskorea

Seegene Reports 12.8% Revenue Growth Amid Strong Demand for Diagnostic Reagents Businesskorea

Seegene develops monkeypox PCR test - Open Access Government

Seegene develops monkeypox PCR test Open Access Government

Dr.Jong-Yoon Chun, Founder & CEO, Seegene - BBC

Dr.Jong-Yoon Chun, Founder & CEO, Seegene BBC

The role of mouthwash sampling in SARS-CoV-2 diagnosis - medRxiv

The role of mouthwash sampling in SARS-CoV-2 diagnosis medRxiv

How this South Korean company created coronavirus test kits in three weeks - CNN

How this South Korean company created coronavirus test kits in three weeks CNN

CJ OliveNetworks wins Seegene DX business contract - The Korea Economic Daily Global Edition

CJ OliveNetworks wins Seegene DX business contract The Korea Economic Daily Global Edition

Seegene Partners with Thermo Fisher Scientific to Enter U.S. Diagnostics Market - Inside Precision Medicine

Seegene Partners with Thermo Fisher Scientific to Enter U.S. Diagnostics Market Inside Precision Medicine

Seegene to unveil fully automated PCR system CURECA and global data platform STAgora at ADLM 2025 - Express Healthcare

Seegene to unveil fully automated PCR system CURECA and global data platform STAgora at ADLM 2025 Express Healthcare

Korean firm Seegene expands influence in Italy's PCR diagnostic industry - BioSpectrum Asia

Korean firm Seegene expands influence in Italy's PCR diagnostic industry BioSpectrum Asia

Seegene’s SeePlex Multiplex MDx Assays Available for Caliper’s LabChip Dx Platform - Genetic Engineering and Biotechnology News

Seegene’s SeePlex Multiplex MDx Assays Available for Caliper’s LabChip Dx Platform Genetic Engineering and Biotechnology News

Top Seegene Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant